The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II randomized, double-blind study of sipuleucel-T followed by IDO pathway inhibitor, indoximod, or placebo in the treatment of patients with metastatic castration resistant prostate cancer (mCRPC).
 
Gautam Gopalji Jha
Consulting or Advisory Role - Exelixis; Prometheus
 
Shilpa Gupta
Consulting or Advisory Role - Exelixis; Genentech; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Pfizer
Research Funding - Astellas Medivation (Inst); Innocrin Pharma (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst)
 
Scott T. Tagawa
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Endocyte; Genentech; Immunomedics; Janssen; Medivation; Sanofi
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Joseph S Koopmeiners
No Relationships to Disclose
 
Sithara Vivek
No Relationships to Disclose
 
Arkadiusz Z. Dudek
Employment - Adhaere Pharmaceuticals
Leadership - IGF Oncology; Martell diagnostic
Stock and Other Ownership Interests - Adhaere Pharmaceuticals; Biothera; IGF Oncology; Vanquish Oncology
Honoraria - Biothera; IGF Oncology; Medtronic; Vanquish Oncology
Consulting or Advisory Role - Biothera; TTC Oncology; Vanquish Oncology
 
Sarah A. Cooley
No Relationships to Disclose
 
Bruce R. Blazar
Leadership - Tmunity Therapeutics, Inc.
Consulting or Advisory Role - Five Prime Therapeutics; Kyocera; SAB-Pharma
Research Funding - Kadmon
 
Jeffrey S. Miller
Consulting or Advisory Role - Celgene; Fate Therapeutics; Oxis International
Research Funding - Fate Therapeutics; Oxis International